End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
2017 | Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA. | CI |
2017 | Neol Biosolutions Seeks Investors | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
5.19M | - | - | - | - | - | |
122B | ||||||
116B | ||||||
27.03B | - | |||||
20.36B | - | |||||
16.43B |
- Stock Market
- Equities
- NEU Stock
- Charts Neuron Bio, S.A.
- Sector Chart